3rd Quarter - Report

PLASTICS INDUSTRY ASSOCIATION, INC. for PLASTICS INDUSTRY ASSOCIATION, INC.

Firm
Client
Income
—
Expenses
$95,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Food Industry (safety, labeling, etc.) FOO

F.Y. 2014 House and Senate Appropriations legislation -- FDA funding

LobbyistCovered position, as disclosed
JOHN GRANT —
JONATHAN KURRLE —
SUZANNE MORGAN —

Contacted: Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

The Miscellaneous Tariff Bill (MTB) (H.R. 2708) Transatlantic Trade and Investment Partnership Agreement (TTIP) Trans-Pacific Partnership Agreement (TPP)

LobbyistCovered position, as disclosed
WILLIAM ROBERT CARTEAUX —
JOHN GRANT —
JONATHAN KURRLE —
MICHAEL TAYLOR —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 2708 (113th)

Taxation/Internal Revenue Code TAX

Research & Experimentation tax credit extension Last-in/First-out (LIFO) accounting method preservation (no specific bill) R&D Tax Credit (No specific bill) F.Y. 2014 House and Senate Appropriations Legislation

LobbyistCovered position, as disclosed
JOHN GRANT —
JONATHAN KURRLE —
SUZANNE MORGAN —

Contacted: SENATE; Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Energy/Nuclear ENG

Energy Costs & Access, including Outer Continental Shelf (no specific bill) New Alternative Transportation to Give Americans Solutions Act of 2013 (H.R. 1364) Hydraulic Fracturing (no specific bill) Energy Savings and Industrial Competitiveness Act of 2013 (S. 1392/ H.R. 1616)

LobbyistCovered position, as disclosed
WILLIAM ROBERT CARTEAUX —
JOHN GRANT —
JONATHAN KURRLE —
SUZANNE MORGAN —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 1364 (113th), S. 1392 (113th), H.R. 1616 (113th)

Environment/Superfund ENV

Proposed Toxic Substances Control Act revisions (S.1009, S. 696) Reimposition of Superfund tax (no specific bill) Congressional Oversight of EPA (no specific bill)

LobbyistCovered position, as disclosed
JOHN GRANT —
JONATHAN KURRLE —
SUZANNE MORGAN —

Contacted: Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 696 (113th), S. 1009 (113th)

Labor Issues/Antitrust/Workplace LBR

The Preventing Greater Uncertainty in Labor Management Relations Act (H.R. 1120) Protecting Americas Workers Act (PAWA) (S. 665) Secret Ballot Protection Act (H.R. 2346) Representation Fairness Restoration Act (H.R. 2347)

LobbyistCovered position, as disclosed
WILLIAM ROBERT CARTEAUX —
JOHN GRANT —
JONATHAN KURRLE —
PATRICIA DAVITT LONG New —
SUZANNE MORGAN —

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: H.R. 1120 (113th), H.R. 2347 (113th), H.R. 2346 (113th), S. 665 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.